NCT05241613 2025-02-13A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate CancerAccutar Biotechnology IncPhase 1 Terminated28 enrolled
NCT05673109 2024-01-25A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate CancerAccutar Biotechnology IncPhase 1 Terminated8 enrolled